Additional targets such as APP (amyloid precursor protein) implicate potential connections to Alzheimer’s disease pathology, while MMP9 (matrix metalloproteinase-9) may modulate extracellular matrix remodeling and blood–brain barrier integrity [35,36]. This evidence concerns the gene MMP9 and early-onset autosomal dominant Alzheimer disease.